Coeptis Therapeutics, Inc.
NASDAQ:COEP · NASDAQ Capital Market
+$0.73 today
Vol 0.13M · Avg 0.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+131.49%
Period High
$18.80
Period Low
$7.05
Latest
$16.32
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$204.42M
Century Therapeutics, Inc.
NASDAQ:IPSC
$198.24M
Equillium, Inc.
NASDAQ:EQ
$108.34M
OS Therapies Incorporated
AMEX:OSTX
$85.96M
Cue Biopharma, Inc.
NASDAQ:CUE
$74.79M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$68.62M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$65.00M
Telomir Pharmaceuticals, Inc. Common Stock
TELO
$48.82M
Senti Biosciences, Inc.
SNTI
$24.50M
Medicus Pharma Ltd. Common Stock
MDCX
$10.08M
What is the latest COEP filing?
The latest filing shown is 424B3 dated Jun 18, 2026.
How many recent filings does COEP have?
Intrinsic Alpha currently shows 20 recent filings for COEP.
Explore More
Continue the stock analysis
Jump to another research area for this company.